Recent research has established that the gut microbiota and its associated metabolic products are fundamental regulators of immune checkpoint blockade (ICB) efficacy in cancer treatment. These microorganisms influence therapeutic outcomes through various mechanisms, including antigenic cross-reactivity, the movement of microbes to lymph nodes, and the systemic circulation of metabolites like short...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动